Qualifying a New Peptide Lot in a Bioassay: The Overlap Experiment Nobody Budgets For

Short answer: run the outgoing lot and the incoming lot side by side in the same assay, on the same day, before the old lot is exhausted. A lot change made without an overlap experiment is an uncontrolled variable introduced into the middle of a dataset.

• A certificate of analysis establishes chemical identity, not equivalent behaviour in a specific assay.
• The overlap has to happen while both lots still exist, which makes it a planning problem rather than a technical one.
• Full concentration-response on both lots is more informative than a single-point comparison.
• The date of a lot change belongs in the laboratory record so that later drift can be attributed.

Why is a certificate of analysis not sufficient?

Because it answers a different question. A certificate confirms that the material is the intended sequence at a stated chromatographic purity under stated conditions. That is necessary and it is not the same as demonstrating that the new lot produces the same response in a particular biological system.

Several things can differ between two lots that both meet specification. The impurity profile can differ, and a deletion sequence retaining partial activity behaves differently from an inert truncation. Peptide content can differ, which means the same weighed mass is a different molar concentration. The counterion load can differ if the purification was not identical. Aggregation state on reconstitution can differ. None of these violate the specification, and all of them can move an assay result.

What does the overlap experiment look like?

Both lots prepared fresh on the same day, from the same solvent, in the same consumables, and run in the same assay plate or the same session with the same reference control. A full concentration-response series on each rather than a single concentration, because a potency shift and an efficacy change look identical at one point and quite different across a curve.

The comparison is then made on the curve parameters, with the assay’s own historical variability as the yardstick. A small difference inside the normal plate-to-plate range is not a finding. A shift outside it is, and it is better found during qualification than inferred later from a dataset that quietly changed character.

When should it be run?

Before the outgoing lot runs out, which is the part that goes wrong. The overlap is impossible once the old lot is gone, and the usual failure is not technical but logistical: the last vial is consumed, the new lot arrives, and the comparison can no longer be made at all.

The practical fix is to reserve a qualification portion of each lot at the point of receipt and treat it as not available for experiments. Reordering before the stock is down to its last portion gives the overlap room to happen. Where a supplier publishes lot-level documentation per product, as Bluum Peptides does, it is also worth comparing the two certificates before the assay is run, since an obvious difference in peptide content or impurity profile tells the laboratory what to expect.

What if the lots do not match?

Investigate before replacing. Compare the certificates for peptide content, purity, method conditions and impurity profile. Confirm the concentrations were calculated from peptide content rather than vial mass, since that alone explains a proportion of apparent lot differences. Check whether the new material dissolved as readily, because incomplete dissolution produces a genuinely lower concentration than the nominal figure.

If the difference survives those checks, it is a conversation with the supplier with specific evidence attached rather than a complaint. Suppliers can often tell a buyer whether the synthesis route, purification system or counterion changed between lots, and that answer frequently identifies the cause in one exchange.

What should be recorded?

The lot identifier against every experiment, not just against the stock. The date of the lot change. The qualification data for the new lot. And the location of the reserved qualification portion of the outgoing lot. With those four items, a shift in results six months later can be tested against the lot change in an afternoon. Without them, it cannot be tested at all.

Frequently asked questions

How many concentrations are needed to qualify a new lot?
Enough to define the curve rather than a single point, since a potency shift and a change in maximal response are indistinguishable at one concentration. A standard concentration-response series run on both lots in the same session is the usual minimum.

Can a new lot be qualified after the old one is gone?
Not directly. The fallback is comparison against the assay’s historical performance with a reference control, which is weaker evidence because assay drift and lot difference cannot be separated.

Do two lots with the same purity figure behave the same?
Not necessarily. Equal purity figures can sit over different impurity profiles, different peptide content and different counterion loads, all of which can affect an assay result.

Should the lot number be recorded in a publication?
It is good practice. Reporting the supplier and lot identifier is what allows another group to recognise, later, whether an irreproducible result coincided with a reagent change.

This article is provided for research and informational purposes only. The materials discussed are laboratory reagents intended for in vitro and preclinical research use. Nothing here describes or endorses use in humans, and no claim is made regarding any outcome, benefit, or application beyond laboratory research.